[Research Report] The metabolomics services market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% from 2021 to 2028.

Metabolomics is the study and analysis of biological processes involving metabolic intermediates and byproducts—metabolomes. The metabolomes include secondary metabolites, signaling molecules, hormones, and metabolic intermediates.

The report offers an in-depth analysis of the metabolomics services market, emphasizing on market trends, technological advancements, market dynamics, and competitive landscape (involving major market players across the world). It also includes the impact of the COVID-19 pandemic on the market across all the major regions. North America holds the largest market share, and the market growth in this region is attributed to high awareness and acceptance for metabolomics services, increasing number of online retails, and rising number of product innovations and launches. Moreover, the growing spending by sex technology companies are also likely to have positive impact on the North America metabolomics services market during the forecast period. The market, by region, is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM).

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Metabolomics Services Market: Strategic Insights

Metabolomics Services Market

• 
  CAGR (2021 - 2028)

  20.9%
• Market Size 2021
  US$ 501.24 Million
• Market Size 2028
  US$ 1,895.14 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• BASF SE
• TMIC
• Creative Proteomics
• BGI
• RTI International
• Afekta Technologies Ltd.
• Fred Hutchinson Cancer Research Center
• West Coast Metabolomics Center
• Molecular You

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Service Type

• Targeted Metabolomics Service and Untargeted Metabolomics Service

Application

• Pharmaceutical and Biotechnology Industry
• Agritech
• Environment

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Market Insights

Rising Incidences of Cancer Fuels Metabolomics Services Market Growth

Metabolomics is among the growing and robust technologies for detecting a wide range of metabolites in tissues and biofluids. This process has a significant application in the analysis and studies associated with cancer disease. The rising prevalence of different types of cancer is expected to drive the market during the forecast period. Cancer diagnostics play an essential role in cancer treatment. As per the data published by the World Health Organization (WHO) in September 2021, nearly 70% of deaths from cancer were reported from the low- and middle-income countries across the globe. The total global share of cancer incidence share as per the Global Cancer Observatory records are breast (2.26 million cases 11.7%), lung (2.21 million cases 11.4%), colon and rectum (1.93 million cases 10%), prostate (1.41 million cases 7.3%), stomach (1.09 million cases 5.6%). Below are the details regarding the regional prevalence in 2020:

Service Type-Based Insights

The metabolomics services market, based on service type, has been segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold a larger market share in 2021. Moreover, the targeted metabolomics service segment is anticipated to register a higher CAGR in the market during the forecast period.

Application-Based Insights

The metabolomics services market, based on application, is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market in 2021. Moreover, the market for this segment is expected to grow at the fastest CAGR of 21.6% during 2021 to 2028.

The metabolomics services market players adopt organic strategies such as product launch and expansion to expand their global footprint and product portfolio.

Metabolomics Services Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

By Service Type

• Targeted Metabolomics Service
• Untargeted Metabolomics Service

By Application

• Pharmaceutical and Biotechnology Industry
  • Biomarker Discovery
  • Drug Discovery
  • Toxicological Testing
  • Others
• Agritech
• Environment

By

Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• BASF SE           
• TMIC      
• Creative Proteomics     
• BGI        
• RTI International         
• Afekta Technologies Ltd.        
• Fred Hutchinson Cancer Research Center    
• West Coast Metabolomics Center      
• Molecular You    
• Metabolon, Inc.           
• biocrates life sciences ag       
• Chenomx Inc.             
• C-CAMP            
• metaSysX         
• MS-Omics